Transfert de gène de chimiorésistance dans les cellules souches hématopoïétiques : promesses et controverses = Chemoresistance gene transfer into hematopoietic cells : hope and pitfallsMACHIELS, J.-P; DHONDT, V.MS. Médecine sciences. 2000, Vol 16, Num 3, pp 395-403, issn 0767-0974Article

L'ÈRE DES MOLÉCULES INTELLIGENTES: de la chimiothérapie anticancéreuse classique aux traitements ciblés et à la médecine personnaliséeSYMANN, M; MACHIELS, J.-P.Louvain médical. 2012, Vol 131, Num 4, issn 0024-6956, 179-185 [9 p.]Article

Thérapies ciblées dans le carcinome rénal: description de la voie signalétique mTOR (mammalian Target Of Rapamycin) et de l'importance de son inhibition dans le traitement rétique mTOR (mamma- du carcinome rénal Rapamycin) joue un rôleSERONT, E; MACHIELS, J.-P.Louvain médical. 2010, Vol 129, Num 4, pp 133-137, issn 0024-6956, 5 p.Article

Guide pratique, à l'usage du, médecin généraliste, des traitements systémiques utilisés dans le cancer du sein: indications et effets secondaires: La chimiothérapie anticancéreuse conventionnelle et l'hormonothérapieMACHIELS, J. P; SYMANN, M.Louvain médical. 2012, Vol 131, Num 4, issn 0024-6956, 186-191 [6 p.]Article

Chimiothérapie du cancer prostatique hormonorésistantMACHIELS, J.-P; TOMBAL, B.Louvain médical. 2004, Vol 123, Num 4, pp S194-S198, issn 0024-6956Conference Paper

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkersSERONT, E; ROTTEY, S; GOEMINNE, J. C et al.Annals of oncology. 2012, Vol 23, Num 10, pp 2663-2670, issn 0923-7534, 8 p.Article

Cancer and renal insufficiency results of the BIRMA studyJANUS, N; LAUNAY-VACHER, V; DERAY, G et al.British journal of cancer. 2010, Vol 103, Num 12, pp 1815-1821, issn 0007-0920, 7 p.Article

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancerMACHIELS, J.-P; SEMPOUX, C; LAURENT, S et al.Annals of oncology. 2007, Vol 18, Num 4, pp 738-744, issn 0923-7534, 7 p.Article

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neckSCHMITZ, S; HAMOIR, M; LONNEUX, M et al.Annals of oncology. 2013, Vol 24, Num 9, pp 2261-2266, issn 0923-7534, 6 p.Article

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)SCHMITZ, S; KAMINSKY-FORRETT, M.-C; HAMOIR, M et al.Annals of oncology. 2012, Vol 23, Num 8, pp 2153-2161, issn 0923-7534, 9 p.Article

Cancer du col utérin et épanchement péricardique = Uterine cervical carcinoma and pericardial effusionVOKAER, B; MACHIELS, J.-P; VANSNICK, F et al.Revue médicale de Bruxelles. 2007, Vol 28, Num 5, pp 439-444, issn 0035-3639, 6 p.Article

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer : the RadiOxCape studyMACHIELS, J.-P; DUCK, L; CANON, J.-L et al.Annals of oncology. 2005, Vol 16, Num 12, pp 1898-1905, issn 0923-7534, 8 p.Article

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancerZAMAN, K; DURANDO, X; BAURAIN, J.-F et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 689-696, issn 0167-6806, 8 p.Article

BRONCHOBILIARY FISTULA AND CHOLANGIOCARCINOMA : A CASE REPORT AND PRINCIPLES OF MANAGEMENTDELANDE, S; GOFFETTE, P; VERBAANDERT, C et al.Acta Clinica Belgica. 2007, Vol 62, Num 6, pp 438-441, issn 0001-5512, 4 p.Article

Physiopathologie et nouvelles stratégies thérapeutiques des métastases osseuses du cancer de la prostate : Du laboratoire au lit du maladeTOMBAL, B; TAJEDDINE, N; MACHIELS, J.-P et al.Louvain médical. 2004, Vol 123, Num 4, pp S172-S179, issn 0024-6956Conference Paper

A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumorsVERMORKEN, J. B; ROTTEY, S; EHRNROOTH, E et al.Annals of oncology. 2013, Vol 24, Num 5, pp 1392-1400, issn 0923-7534, 9 p.Article

PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activationSERONT, E; PINTO, A; BOUZIN, C et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1586-1592, issn 0007-0920, 7 p.Article

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumoursSERONT, E; BOIDOT, R; BOUZIN, C et al.British journal of cancer. 2013, Vol 109, Num 10, pp 2597-2606, issn 0007-0920, 10 p.Article

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinomaNUTTING, C. M; VAN HERPEN, C. M. L; MIAH, A. B et al.Annals of oncology. 2009, Vol 20, Num 7, pp 1275-1279, issn 0923-7534, 5 p.Article

Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factorsGOEMINNE, J.-C; GUILLAUME, T; SALMON, M et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 7, pp 769-775, issn 0268-3369Article

Reversible myocardial dysfunction in a patient with alcoholic ketoacidosis : A role for hypophosphatemiaMACHIELS, J. P; DIVE, A; DONCKIER, J et al.The American journal of emergency medicine. 1998, Vol 16, Num 4, pp 371-373, issn 0735-6757Article

Quand est-il utile de doser un marqueur tumoral ? : La prescription responsable 2e partie: la biologieMACHIELS, J. P.Louvain médical. 2006, Vol 125, Num 5, issn 0024-6956, S140-S143Conference Paper

EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED THERAPIES FOR SOLID TUMOURSVAN DEN EYNDE, M; BAURAIN, J. F; MAZZEO, F et al.Acta clinica belgica (Ed. multilingue). 2011, Vol 66, Num 1, pp 10-17, issn 0001-5512, 8 p.Article

Unusual atrial pro-arrhythmic effect of flecainide : A contemporary reviewDE MEESTER, A; MACHIELS, J. P; ROUSSEAU, L et al.Acta cardiologica. 1996, Vol 51, Num 6, pp 529-534, issn 0001-5385Conference Paper

Page / 2